Thierry Petit

2PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Mar 07, 2024
Neoadjuvant anthracycline-based (5-FEC) or anthracycline-free (docetaxel/carboplatin) chemotherapy plus trastuzumab and pertuzmab in HER2 + BC patients according to their TOP2A: a multicentre, open-label, non-randomized phase II trial.

Angeline Ginzac, Ioana Molnar, Xavier Durando

|Jul 24, 2023
Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trial.

Fernanda Mosele, Elise Deluche, Amelie Lusque

Pageof 1

Frequent Collaborators

1 joint publications

Fernanda Mosele

1 joint publications

Elise Deluche

1 joint publications

Yoann Pradat

1 joint publications

Barbara Pistilli